MMSL 2011, 80(2):58-64 | DOI: 10.31482/mmsl.2011.009

METHOD OPTIMIZATION FOR ACETYLCHOLINESTERASE MODULATORS-ALBUMIN INTERACTIONSOriginal article

Filip Zemek1, Jana ®ďárová Karasová ORCID...2*, Kamil Musílek ORCID...1, Kamil Kuča ORCID...3
1 Department of Toxicology, Faculty of Health Sciences, Defence University, Hradec Kralove, Czech Republic
2 Department of Public Health, Faculty of Health Sciences, Defence University, Hradec Kralove, Czech Republic
3 Centre of Advance Studies, Faculty of Health Sciences, Defence University, Hradec Kralove, Czech Republic

Plasma proteins such as human serum albumin (HSA) and alpha 1-acid glycoprotein (AGP) play an important role in the pharmacokinetic and pharmacodynamic properties of all endogenous or exogenous substances presented in the blood vessels. Their abundance in human blood not only helps to maintain hemostasis, but also makes them ideal candidates as transporters or possible depot reservoirs. Numerous methods e.g. equilibrium dialysis, ultrafiltration. ultracentrifugation, high-performance affinity chromatography were introduced to determine potential interactions with plasma proteins and possible quantification.In this work method was developed for the determination of drug-human serum albumin interactions and applied to obtain pharmacokinetic profile of AChE modulators prepared at the Faculty of Military Health Sciences. For method validation commercially used compounds HI-6 and obidoxime were chosen. HI-6 did not bind at all while obidoxime showed 7 % binding potency.

Keywords: human serum albumin; alpha 1-acid glycoprotein; plasma proteins; acetylcholinreactivators; drug-protein interaction

Received: April 20, 2011; Revised: May 27, 2011; Published: June 10, 2011  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Zemek, F., ®ďárová Karasová, J., Musílek, K., & Kuča, K. (2011). METHOD OPTIMIZATION FOR ACETYLCHOLINESTERASE MODULATORS-ALBUMIN INTERACTIONS. MMSL80(2), 58-64. doi: 10.31482/mmsl.2011.009
Download citation

References

  1. Miller, L. L.; Bale, W. F. Synthesis of all plasma protein fractions except gamma-globulins by the liver-the use of zone electrophoresis and lysine-epsilon-c-14 to define the plasma proteins synthesized by the isolated perfused liver. J. Exp. Med. 1954, 99, 125-132 Go to original source... Go to PubMed...
  2. Swenson, R. M.; Kern, M. Synthesis and secretion of gamma-globulins by lymph node cells.I. microsomal compartmentalization of gamma-globulins. Proceedings of The NationalAcademy of Sciences of the United States of America 1967, 57, 417 Go to original source... Go to PubMed...
  3. Kukral, J. C.; Winzler, R. J.; Louch, J.; Sporn, J. Synthesis of alpha- and beta- globulins in normal and liverless dog. Amer. J. Phsych. 1963, 204, 262 Go to original source...
  4. Peters, T. Jr.; Anfinsen, C. B. Net production of serum albumin by liver slices. J. Biol. Chem. 1950 186: 805-813 Go to original source...
  5. Kremer, J. M.; Wilting, J.; Jansen, L. H. Drug binding to human alpha 1-acid glycoprotein in health and disease. Pharmacol. Rev. 1988, 40: 1-47 Go to PubMed...
  6. Holbrook, A. M; Pereira, J. A; Labiris, R; McDonald, H; Douketis, J. D; Crowther, M; Wells, P. S. Systematic overview of warfarin and its drug and food interactions. Arch. Intern. Med. 2005, 165: 1095-1106. Go to original source... Go to PubMed...
  7. Dunner, D. L. Drug interactions of lithium and other antimanic/mood-stabilizing medications.J. Clin. Psichiatry 2003, 64 Suppl 5: 38-43.
  8. Sugio, S.; A.Kashima, S.; Mochizuki, S.; Noda, M.; Kobayashi, K. Crystal structure of human serum albumin at 2.5 Ǻ resolution. Protein Eng.1999, 12: 439- 446 Go to original source... Go to PubMed...
  9. Watanabe, H.; Tanase, S.; Nakajou, K.; Marauyama, T.; Kragh-Hansen, U.; Otagiri, M. Role of Arg-410 and Tyr-411 in human serum albumin for ligand binding and esterase-loke activity. Biochem. J.2000, 349: 813-819 Go to original source... Go to PubMed...
  10. Peters, T. All about albumin; biochemistry, genetics and medical applications. Academic Press: San Diego, CA1996 Go to original source...
  11. Oettl, K.; Satuber, R. E. Physiological and pathological changes in the redox state of human serum albumin critically influence its binding properties. Br. J. Pharmacol.2007, 151: 580-590 Go to original source... Go to PubMed...
  12. Curry, S. Lessons from the crystallographic analysis of the small molecule binding to human serum albumin. Drug Metab. Pharmacokinet. 2009, 24: 342-357 Go to original source... Go to PubMed...
  13. Kragh-Hansen, U.; Chuang, V. T. G.; Otagiri, M. Practical aspects of the ligand-binding and enzymatic properties of human serum albumin. Biol.Pharm. Bull. 2002, 25: 695-704 Go to original source... Go to PubMed...
  14. Sudlow, G.; Birkett, D. J.; Wade, D. N. The Characterization of two specific drug binding sites on human serum albumin. Molecular Pharmacol. 1975, 11: 824-832
  15. Hage, D. S.; Austin, J. High-performance affinity chromatography and immobilized serum albumin as probes for drug- and hormone-binding. J. Chromatogr. B. Biomed. Sci. Appl. 2000, 739: 39-54 Go to original source... Go to PubMed...
  16. Kim, H. S.; Wainer, I. W. Rapid analysis of the interactions between drugs and human serum albumin (HSA) using high-performance affinity chromatography (HPAC). J. Chromatogr. B. Biomed. Sci. Appl. 2008, 870: 22-26 Go to original source... Go to PubMed...
  17. Phizicky, E. M; Fields, S. Protein-Protein Interactions: Methods for Detection and AnalysisProtein-Protein Interactions: Methods for Detection and Analysis. Microbiol. Rev.1995, 59: 94-123 Go to original source... Go to PubMed...
  18. Karasova, J. Z.; Novotny, L.; Antos, K.; Zivna, H.; Kuca, K. Time-dependent changes in concentration of two clinically used acetycholinesterase reactivators (HI-6 and obidoxime) in rat plasma determined by HPLC techniques after in vivo administration. Anal. Sci.2010, 26: 63-67 Go to original source... Go to PubMed...
  19. Karasova, J. Z.; Zemek, F.; Bajgar, J.; Vasatova, M.; Prochazka, P.; Novotny, L.; Kuca, K. Partition of bispyridinium oximes (trimedoxime and K074) administered in therapeutic doses into different parts of the rat brain. J. Pharm. Biomed. Anal. 2011, 54: 1082-1087 Go to original source... Go to PubMed...
  20. Karasova, J.Z.; Chladek, J.; Hroch, M.; Fusek, J.; Hnidkova, D.; Kuca, K. Pharmacokinetics study of two acetylcholinesterase reactivators, trimedoxime and newly synthesized oxime K027, in rat plasma. J. Appl. Toxicol. 2011, In press Go to original source...